Listeria monocytogenes induced Rac1-dependent signal transduction in endothelial cells

Biochemical Pharmacology

Volumn 72, Issue 11, 2006, Pages 1367-1374

  Schmeck, Bernd ^a   Beermann, Wiebke ^a   van Laak, Vincent ^a   Opitz, Bastian ^a   Hocke, Andreas C ^a   Meixenberger, Karolin ^a   Eitel, Julia ^a   Chakraborty, Trinad ^b   Schmidt, Gudula ^c   Barth, Holger ^d   Suttorp, Norbert ^a   Hippenstiel, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

Bacterial toxins; Cytokines; Endothelial cells; Histones; Listeria; Rac1

Indexed keywords

RAC1 PROTEIN;

ACETYLATION; ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM LIMOSUM; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AMINOQUINOLINES; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELLS, CULTURED; CYTOKINES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ESCHERICHIA COLI PROTEINS; HUMANS; LISTERIA MONOCYTOGENES; PYRIMIDINES; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; UMBILICAL VEINS;

EID: 33750514378     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.06.033     Document Type: Article

References (50)

1. Flo T.H., Halaas O., Lien E., Ryan L., Teti G., Golenbock D.T., et al. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 164 (2000) 2064-2069
2. Pamer E.G. Immune responses to Listeria monocytogenes. Nat Rev Immunol 4 (2004) 812-823
3. Hain T, Steinweg C, Chakraborty T. Comparative and functional genomics of Listeria spp. J Biotechnol 2006.
4. Glaser P., Frangeul L., Buchrieser C., Rusniok C., Amend A., Baquero F., et al. Comparative genomics of Listeria species. Science 294 (2001) 849-852
5. Krull M., Nost R., Hippenstiel S., Domann E., Chakraborty T., and Suttorp N. Listeria monocytogenes potently induces up-regulation of endothelial adhesion molecules and neutrophil adhesion to cultured human endothelial cells. J Immunol 159 (1997) 1970-1976
6. Kayal S., Lilienbaum A., Poyart C., Memet S., Israel A., and Berche P. Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Mol Microbiol 31 (1999) 1709-1722
7. Rose F., Zeller S.A., Chakraborty T., Domann E., Machleidt T., Kronke M., et al. Human endothelial cell activation and mediator release in response to Listeria monocytogenes virulence factors. Infect Immun 69 (2001) 897-905
8. Czuprynski C.J., Brown J.F., Maroushek N., Wagner R.D., and Steinberg H. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 152 (1994) 1836-1846
9. Harty J.T., and Bevan M.J. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 3 (1995) 109-117
10. Roesler J., Kofink B., Wendisch J., Heyden S., Paul D., Friedrich W., et al. Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options. Exp Hematol 27 (1999) 1368-1374
11. Rogers H.W., and Unanue E.R. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 61 (1993) 5090-5096
12. Schwarzer N., Nost R., Seybold J., Parida S.K., Fuhrmann O., Krull M., et al. Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-kappa B activation, and E-selectin expression in human endothelial cells. J Immunol 161 (1998) 3010-3018
13. Portnoy D.A., Schreiber R.D., Connelly P., and Tilney L.G. Gamma interferon limits access of Listeria monocytogenes to the macrophage cytoplasm. J Exp Med 170 (1989) 2141-2146
14. Opitz B., Puschel A., Beermann W., Hocke A.C., Forster S., Schmeck B., et al. Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells. J Immunol 176 (2006) 484-490
15. Avni O., Lee D., Macian F., Szabo S.J., Glimcher L.H., and Rao A. T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol 3 (2002) 643-651
16. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 (2000) 41-45
17. Muegge K. Preparing the target for the bullet. Nat Immunol 3 (2002) 16-17
18. Saccani S., Pantano S., and Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3 (2002) 69-75
19. Schmeck B., Beermann W., van L.V., Zahlten J., Opitz B., Witzenrath M., et al. Intracellular bacteria differentially regulated endothelial cytokine release by MAPK-dependent histone modification. J Immunol 175 (2005) 2843-2850
20. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
21. Hippenstiel S., Soeth S., Kellas B., Fuhrmann O., Seybold J., Krull M., et al. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood 95 (2000) 3044-3051
22. Arbibe L., Mira J.P., Teusch N., Kline L., Guha M., Mackman N., et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1 (2000) 533-540
23. Hippenstiel S., Schmeck B., N'Guessan P.D., Seybold J., Krull M., Preissner K., et al. Rho protein inactivation induced apoptosis of cultured human endothelial cells. Am J Physiol Lung Cell Mol Physiol 283 (2002) L830-L838
24. Just I., Wilm M., Selzer J., Rex G., Eichel-Streiber C., Mann M., et al. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270 (1995) 13932-13936
25. Just I., Selzer J., Wilm M., Eichel-Streiber C., Mann M., and Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375 (1995) 500-503
26. Sekine A., Fujiwara M., and Narumiya S. Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. J Biol Chem 264 (1989) 8602-8605
27. Aktories K., Wille M., and Just I. Clostridial actin-ADP-ribosylating toxins. Curr Top Microbiol Immunol 175 (1992) 97-113
28. Barth H., Roebling R., Fritz M., and Aktories K. The binary Clostridium botulinum C2 toxin as a protein delivery system: identification of the minimal protein region necessary for interaction of toxin components. J Biol Chem 277 (2002) 5074-5081
29. Barth H., Hofmann F., Olenik C., Just I., and Aktories K. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin. Infect Immun 66 (1998) 1364-1369
30. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., and Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387 (1997) 725-729
31. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., Fiorentini C., et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387 (1997) 729-733
32. Hoffmann C., Pop M., Leemhuis J., Schirmer J., Aktories K., and Schmidt G. The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. J Biol Chem 279 (2004) 16026-16032
33. Gao Y., Dickerson J.B., Guo F., Zheng J., and Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 101 (2004) 7618-7623
34. Hippenstiel S., Schmeck B., Seybold J., Krull M., Eichel-Streiber C., and Suttorp N. Reduction of tumor necrosis factor-alpha (TNF-alpha) related nuclear factor-kappaB (NF-kappaB) translocation but not inhibitor kappa-B (Ikappa-B)-degradation by Rho protein inhibition in human endothelial cells. Biochem Pharmacol 64 (2002) 971-977
35. Schmeck B., Brunsch M., Seybold J., Krull M., Eichel-Streiber C., Suttorp N., et al. Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells. Inflammation 27 (2003) 89-95
36. Schmeck B., Zahlten J., Moog K., van L.V., Huber S., Hocke A.C., et al. Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor. J Biol Chem 279 (2004) 53241-53247
37. Gruenheid S., and Finlay B.B. Microbial pathogenesis and cytoskeletal function. Nature 422 (2003) 775-781
38. Vazquez-Boland J.A., Kuhn M., Berche P., Chakraborty T., Dominguez-Bernal G., Goebel W., et al. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 14 (2001) 584-640
39. Jaffe A.B., and Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21 (2005) 247-269
40. Conlan J.W., and North R.J. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 179 (1994) 259-268
41. North R.J. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J Exp Med 132 (1970) 521-534
42. Singh R., Wang B., Shirvaikar A., Khan S., Kamat S., Schelling J.R., et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 103 (1999) 1561-1570
43. Munro P., Flatau G., Doye A., Boyer L., Oregioni O., Mege J.L., et al. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J Biol Chem 279 (2004) 35849-35857
44. Grassl G.A., Kracht M., Wiedemann A., Hoffmann E., Aepfelbacher M., Eichel-Streiber C., et al. Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell Microbiol 5 (2003) 957-971
45. Hoshimoto A., Suzuki Y., Katsuno T., Nakajima H., and Saito Y. Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br J Pharmacol 136 (2002) 280-286
46. Ashburner B.P., Westerheide S.D., and Baldwin Jr. A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21 (2001) 7065-7077
47. Imhof A., and Wolffe A.P. Transcription: gene control by targeted histone acetylation. Curr Biol 8 (1998) R422-R424
48. Agalioti T., Chen G., and Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111 (2002) 381-392
49. Hoffmann E., Dittrich-Breiholz O., Holtmann H., and Kracht M. Multiple control of interleukin-8 gene expression. J Leukoc Biol 72 (2002) 847-855
50. Ebel F., Rohde M., Eichel-Streiber C., Wehland J., and Chakraborty T. The actin-based motility of intracellular Listeria monocytogenes is not controlled by small GTP-binding proteins of the Rho- and Ras-subfamilies. FEMS Microbiol Lett 176 (1999) 117-124